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Abstract
Background/Aims: Diabetic cardiomyopathy (DCM) is characterized by structural and 
functional alterations that can lead to heart failure. Several mechanisms are known to be involved 
in the pathogenesis of DCM, however, the molecular mechanism that links inflammation to 
DCM is incompletely understood. To learn about this mechanism, we investigated the role of 
inflammatory serine proteases (ISPs) during the development of DCM. Methods: Eight weeks 
old mice with deletion of dipeptidyl peptidase I (DPPI), an enzyme involved in the maturation 
of major ISPs, and wild type (WT) mice controls were injected with streptozotocin (50 mg/
kg for 5 days intraperitoneally) and studied after 4, 8, 16, and 20 week after induction of 
type 1 diabetes mellitus (T1DM). Induction of diabetes was followed by echocardiographic 
measurements, glycemic and hemoglobulin A1c profiling, immunoblot, qPCR, enzyme activity 
assays, and immunohistochemistry (IHC) analysis of DPPI, ISPs, and inflammatory markers. 
Fibrosis was determined from left ventricular heart  by Serius Red staining and qPCR. Apoptosis 
was determined by TUNEL assay and immunoblot analysis. Results: In the diabetic WT mice, 
DPPI expression increased along with ISP activation, and DPPI accumulated abundantly in the 
left ventricle mainly from infiltrating neutrophils. In diabetic DPPI-knockout (DPPI-KO) mice, 
significantly decreased activation of ISPs, myocyte apoptosis, fibrosis, and cardiac function 
was improved compared to diabetic WT mice. In addition, DPPI-KO mice showed a decrease 
in overall inflammatory status mediated by diabetes induction which was manifested by 
decreased production of pro-inflammatory cytokines like TNF-α, IL-1β and IL-6. Conclusion: 
This study elucidates a novel role of ISPs in potentiating the immunological responses that 
Khadija Rafiq, PhD Center for Translational Medicine, Thomas Jefferson University
JAH 543A, 1020 Locust St, Philadelphia, PA 19107 (USA)
Tel: +1-215-503-5593, E-Mail khadija.rafiq@jefferson.edu
M. A. Kolpakov and K. Sikder contributed equally to this study.
Cell Physiol Biochem 2019;53:982-998
DOI: 10.33594/000000190
Published online: 13 December 2019 983
Cellular Physiology 
and Biochemistry
© 2019 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Kolpakov et al.: Inflammatory Serine Proteases and DCM
lead to the pathogenesis of DCM in T1DM. To the best of our knowledge, this is the first 
study to report that DPPI expression and activation promotes the inflammation that enhances 
myocyte apoptosis and contributes to the adverse cardiac remodeling that subsequently 
leads to DCM.
IntroductionDiabetes mellitus continues to be among the most common chronic medical conditions 
in the world. Ongoing studies throughout the field attest to the alarming rate of increasing 
incidence of diabetes mellitus (DM) is increasing. Bewteen 2002 and 2012, incidence 
of  T1DM increased by 1.8% and incidence of T2DM increased by 4.8% [1]. According to 
the Global Burden of Disease report published in 2015, the prevalence of  DM rose from 
approximately 333 million people worldwide to 435 million in the ten-year period between 
2005 and 2015 [2].
DM affects nearly every organ system in the human body and claims approximately 
1.5 million lives a year [3]. The heart is particularly vulnerable to DM, with cardiovascular 
diseases (CVDs) accounting for nearly two-thirds of diabetic mortality [1]. CVDs in diabetes 
were traditionally attributed to advanced atherosclerosis, autonomic neuropathy, and 
cardiomyopathy. DCM was first described in 1972 after Rubler et al. found significant left 
ventricular (LV) hypertrophy in the post-mortem hearts of diabetic patients with minimal 
coronary artery disease [4]. Histopathological analysis confirmed significant fibrosis and 
narrowing of coronary arterioles.
The prevalence of DCM is estimated to occur in 30%-60% in individual with DM 
depending on the study [3]. It is a vastly underestimated, enigmatic disease thought to 
result from a combination of hyperglycemia, dyslipidemia, and inflammation. It alters the 
environment, metabolism, and function of myocardium and leads to diastolic dysfunction 
followed by systolic dysfunction. Various mechanisms have been postulated, but because 
of its complicated multifactorial nature, the pathophysiology remains largely unknown [1].
Recently, our lab has worked to prove that inflammation is central to the development 
of DCM [5]. We have shown that chronic inflammation increases leukocyte invasion and 
infiltration in the myocardium where they release ISPs that trigger cardiac dysfunction. 
Previously, we have shown that ISPs regulate numerous biological pathways and signaling 
cascades involved in cardiac remodeling [6, 7]. These findings suggest that ISPs play 
a critical role in the alteration of both the geometry and mechanical properties of the 
myocardium [8, 9].
ISPs represent a broad category of enzymes derived mainly from neutrophils (i.e., 
elastase, proteinase 3, cathepsin G, neutrophil serine protease 4) [10, 11], cytotoxic T cells 
(i.e., granzyme B), and mast cells (i.e., chymase, tryptase). These enzymes predominantly 
function in the killing of intracellular pathogens [12-15]. A study previously published 
from our lab identified cardiomyocytes as the targets of many of these ISPs [6, 7]. For ISPs 
to function, they must be first activated by DPPI, also known as cathepsin C, a lysosomal 
cysteinyl protease that is constitutively expressed in both humans and rodents. Based on 
studies involving DPPI-KO mice, modulation of the activity of DPPI appears to be a selective 
way of inhibiting ISP activation and the subsequent inflammatory cascade [16-21].
DPPI-KO mice have been used to study asthma, chronic obstructive pulmonary disease, 
sepsis, and abdominal aortic aneurysms, with the general consensus being that the DPPI-
KO mice demonstrate less inflammatory cell infiltration, activation, and production of 
inflammatory cytokines [19, 22-25]. To our knowledge, DPPI-KO mice have not been studied 
in the context of DCM. Our study aimed to recapitulate the elevated inflammatory response 
in a DCM mouse model and also to illustrate the critical role that ISPs play in the development 
of DCM using a DPPI-KO version of the DCM mouse model.
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Materials and Methods
Materials
Phospho-p38Thr180/182, phosphor-AKTSer473, Bcl-2, Bax, cleaved-caspase-3, and CHOP antibodies were 
purchased from Cell Signaling Technology (Danvers, MA). AKT and p38 antibodies were purchased from 
Santa Cruz Biotechnology (Dallas, Texas). GRP78 was purchased from Enzo Life Science Inc (Farmingdale, 
NY). GAPDH was purchased from Millipore (Billerica, MA). NIMP-R14, chymase, and granzyme B were 
purchased from Abcam (Cambridge, MA). DPPI was purchased from R&D (Minneapolis, MN). All other 
chemicals were from standard suppliers.
Experimental Animals
Eight-week-old C57BL/6 WT male mice were purchased from Jackson Laboratory (Bar Harbor, ME). 
DPPI-KO mice were provided by Dr. Pham (Washington University School of Medicine, St. Louis, MO) and 
genotyped as previously described [18-20, 26]. These animals were backcrossed to C57BL/6 mice for >10 
generations, using the mutant allele as a marker for selection at each generation. All animals were housed at 
Thomas Jefferson University animal facility at 22 °C with a 12-h light/dark cycle and free access to standard 
rodent chow and tap water. The Institutional Animal Care Committee of Thomas Jefferson University 
approved all the animal protocols utilized in this study.
All animal experiments were conformed to the Guide for the Care and Use of Laboratory Animals published 
by the U.S. National Institutes of Health and approved by the American Physiological Society. Mice were 
divided into four groups: 1) STZ-treated WT mice; 2) WT-controls mice; 3) STZ-treated DPPI-KO mice; and 
4) DPPI-KO-controls mice.
T1DM mouse model
STZ (Sigma-Aldich, St. Louis, MO), dissolved in 0.1 M sodium citrate (pH 4.5) was intraperitoneally 
injected (50 mg/Kg) to induce T1DM. Age matched controls received a vehicle injection (sodium citrate). 
Mice were injected for five consecutive days. This strategy minimizes nonspecific toxic effects of high-dose 
STZ and also provides a robust and consistent hyperglycaemic response [27]. T1DM was confirmed by a 
measurement of fasting blood glucose at greater than 250 mg/dL after anesthetization of animals using the 
inhalational anesthetic, isoflurane (2% for induction in 2L oxygen/min) [28]. Between 4-20 weeks after STZ 
injection, mice were sacrificed after they were anesthetized using an intraperitoneal injection of Ketamine 
(50 mg/kg) and Xylazine (10 mg/kg).
Plasma glycated hemoglobin (HbA1c)
Plasma HbA1c was measured using commercial assay kit following the protocol provided by 
manufacturer (Crystal Chem, Elk Grove Village, IL USA).
Echocardiography
Echocardiographic measurements were taken before and after STZ injection to determine the baseline 
heart function and ventricular dimensions in the experimental groups. Briefly, following light sedation using 
the inhalational anesthetic, isoflurane (2% for induction in 2L oxygen/min), an intraperitoneal injection of 
Ketamine (50 mg/kg) and Xylazine (10 mg/kg) will be administered to achieve semi-conscious sedation for 
20 to 30 minutes. After a complete sedation, the animals received an echocardiogram. Mice were placed on 
a heated platform in the left lateral decubitus position for imaging. All hairs were removed from the thorax 
using a chemical depilatory agent, and aquasonic clear ultrasound gel (Parker Laboratories, Fairfield, NJ) 
was applied to the thorax surface to optimize the visibility of the cardiac chambers. Echocardiography was 
performed using Visualsonic Ultrasound System (Vevo770, Toronto, Canada) containing a 40 Mhz variable 
frequency probe. Standard long axis M-Mode and PW Doppler mode views were recorded when the mouse 
reached a target heart rate between 450 and 550 beats per minute. Posterior wall thickness (LVPWTd, 
LVPWTs) and left ventricular internal diameters (LVEDd, LVESs) were calculated and averaged from 4 
consecutive contractions using manufacturer’s software. Functional calculations were acquired according 
to the guidelines of the American Society of Echocardiography. Heart rate, percent ejection fraction (%EF), 
percent fractional shortening (%FS), mitral peak velocity of early filling (E) to mitral peak velocity of late 
filling (A) E/A ratio were calculated [29].
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Histopathology and immunohistochemistry (IHC)
Tissues were fixed in 10% formalin, embedded in paraffin, and sectioned at 6 μm thickness. Sections 
were stained for DPPI, NIMP-R14 (neutrophil), chymase (mast cells), and granzyme B (cytotoxic T cells) 
antibodies. Wheat germ agglutinin (WGA) staining was carried out to measure cardiomyocyte cell size. All 
images were captured in 400X magnification using bright field microscope (Nikon Eclipse 80i, NIS Elements 
version 4.3). The outline of myocytes was traced in the LV of each animal, using NIH Image J software to 
determine myocyte cross-sectional area. A value from each heart was calculated by the measurements 
of approximately 400–600 cells in a remote area from 5 randomly selected image areas in an individual 
heart. For evaluation of fibrosis, Picro-sirius red staining was performed using standard procedures. For 
immunostaining, paraffin heart sections were deparaffinized in xylene and re-hydrated. Antigen retrieval 
was achieved by boiling the slides in citrate solution for 12-15 minutes and then washing them with 





20 minutes, the slides were washed in PBS and blocked in PBS containing 5% bovine serum albumin (BSA) 
at room temperature for 30 minutes. Primary antibodies were applied overnight at 4°C in PBS containing 
2% BSA. The samples were washed in PBS followed by incubation with Vectastain Elite ABC Kit (Avidin/
Biotin/Horseradish Peroxidase-System, Vector Laboratories). The peroxidase reaction was visualized 
using 3, 3’-diaminobenzidine tetrahydrochloride (DAB) and slides were counterstained with hematoxylin. 
All images were captured in 400X magnification using bright field microscope (Nikon Eclipse 80i, NIS 
Elements version 4.3). Cells were counted using Image J (bundled with 64-bit Java 1.8.0_112) by adjusting 
to a lower and upper (Pixel) threshold (Image, Adjust, Threshold, Set or Auto). Then, using the analyze 
particle tool (Analyze, Analyze Particles), the number of spots  corresponding the positive cells was counted 
automatically.
Terminal deoxynucleotidyl transferase (TdT) and tropomyosin immunolabeling
TdT assay was performed using the kit (Promega, Madison, WI) according to the manufacturer’s 
instructions. Five sections from each left ventricle (LV) cut perpendicularly to the major axis of the heart 
were sampled. TUNEL positive cells were counted throughout the LV and were expressed as percentage 
of the total number of nuclei as determined by DAPI (Molecular probes, Pittsburgh, PA). TUNEL co-
staining with tropomyosin was used to assess the percentage of apoptotic cardiomyocytes. All images were 
captured in 600X magnification using bright field microscope (Nikon Eclipse 80i, NIS Elements version 4.3). 
Quantification was done by ImageJ software (bundled with 64-bit Java 1.8.0_112).
Caspase-3 activity assay
Caspase-3 activity was measured with CaspACE assay system (Promega, Madison, WI) according 
to the manufacturer’s instructions. In brief, LV lysates were prepared by dounce homogenization in lysis 
buffer provided with the kit. The lysates were centrifuged at 12, 000 rpm for 20 minutes at 4 °C, and the 
supernatants containing 40 μg protein were used for caspase-3 assay. Caspase-3 activity was examined 
by measuring the rate of cleavage of fluorogenic conjugated substrate MCAVal-Asp-Gln-Met-Asp-Gly-Trp-
Lys-(DNP)-NH2. The specificity of the assay was confirmed by addition of the specific caspase-3 inhibitor 
Z-DQMD-FMK in the reaction mixture at a concentration of 50 μM during the incubation.
DPPI activity assay
Snap frozen LV-heart tissues were homogenized in ice-cold lysis buffer containing 100 mM acetate 
buffer (pH 5.5), 1 mM EDTA, 0.01% Brij-35, and 5 mM dithiothreitol (DTT). After centrifugation, supernatants 
containing 40 ug proteins were used for DPPI assay by measuring the rate of cleavage of fluorogenic 
conjugated substrate H-Gly-Arg-AMC (Bachem, Torrance, CA). 
Cathepsin G, chymase, and granzyme activity assays
Snap frozen LV tissues were homogenized in ice-cold buffer containing 100 mM HEPES (pH 7.5), 1 
M NaOH, 50 mM CaCl2, and 0.01% Igepal CA630 in the presence or absence of cathepsin G inhibitor. After 
centrifugation, supernatants containing 40 μg proteins were used for cathepsin G, chymase, and granzyme B 
activity assay by measuring the rate of cleavage of fluorogenic conjugated substrate Suc-Ala2-Pro-Phe-Amc 
(R&D Systems, Minneapolis, MN), SucLeu-Leu-Val-Tyr-AMC (Boston Biochem, Cambridge, MA), and Z-Ile-
Glu-Thr-Asp-AFC (MilliporeSigma, Burlington, MA), respectively.
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Immunoblot analysis
Extraction of proteins from heart tissue samples was performed as described previously [30]. Briefly, 
lysates were cleared by centrifugation at 12, 000 rpm and the supernatants were subjected to immunoblot 
analysis according to methods published previously. Each immunoblot panel in the figures represents 
results from a single blot exposed for a uniform duration with bands detected by LI-COR Odyssey imaging 
system (PCSH898; LI-COR, Inc., Nebraska USA).
Quantitative real-time (qRT) PCR
Total RNA were extracted from LV tissue with TRIZOL. cDNA was generated from 2μg of total RNA 
using High Capacity RNA-to-cDNA kit (Life Technology Grand Island, NY) according to the manufacturer’s 
instruction. qRT-PCR assays were performed using PerfeCT Super Green Super Mix (Quanta Biosciences, 
Beverly, MA) by using specific primers IL-6, TNF-α, ANP, BNP, β-MHC, Fibronectin, Collagen I, Collagen IV, 
TGF-β, CTGF, and MMP9. (Integrated DNA Technologies, Inc. Coralville, Iowa). Differences in expression 
were determined by the relative quantification method; the cycle threshold (C
T
) values of the target genes 
were first normalized to the C
T
 values of endogenous control GAPDH.
Statistical analysis
All data are presented as mean ± SEM. Comparison of two groups was accomplished using an unpaired 
Student’s t test. One-way ANOVA followed by the Tukey post hoc test was used to compare multiple groups. 
Two-way ANOVA and subsequent Tukey test were performed to compare groups with different time points. 
A value of P < 0.05 was considered statistically significant.
Results
T1DM leads to increased DPPI expression and its activity
We examined DPPI expression and activity in the lef ventricular hearts of T1DM mice 
from 4 to 20 weeks post-STZ treatment. IHC revealed a steady increase in DPPI expression, 
with peak expression at 4 weeks post-STZ treatment (Fig. 1A & 1B). By comparison, age 
matched WT controls showed little to no expression of DPPI. At 4 weeks post-STZ treatment, 
the T1DM mice expressed an average of 18 ± 0.63 DPPI+ cells/mm2 compared to 1 ± 0.03 
DPPI+ cells/mm2 in the WT controls. DPPI expression was also confirmed via immunoblotting 
at 4 weeks (Fig. 1D).
We also examined enzymatic activity in the WT controls and T1DM mice. We found 
that the enzymatic activity of DPPI was significantly increased in the myocardium of mice 
after diabetes induction as compared to controls, correlating with DPPI expression. DPPI 
expression was 3.6x103 ± 0.28x103 RFU/min/mg protein in the T1DM mice at 4 weeks post-
STZ treatment compared to 1.3x103 ± 0.11x103 RFU/min/mg protein in the control (Fig. 1C).
Since DPPI expression and activation were both highest at 4-weeks post STZ, we chose 
this time point for rest of the studies.
Neutrophils are the predominant DPPI-expressing cells in T1DM heart
To identify which cells were expressing DPPI in the T1DM mice, we performed IHC for 
NIMP-R14 against neutrophils; chymase against mast cells; and granzyme B against cytotoxic 
T cells (CTL) in the heart (Fig. 1E). Interestingly, all three cell types were present in the 
T1DM mouse heart. Additionally, these cells colocalized with DPPI. Neutrophils constituted 
the largest DPPI-positive cell population among all leukocyte subtypes (Fig. 1E & 1F).
Downstream targets of DPPI demonstrate increased activity in T1DM heart
Serine proteases are the downstream targets of DPPI that are cleaved and activated by 
DPPI. These include and are not limited to cathepsin G (CG), chymase, and granzyme B, all of 
which were significantly increased in the present study in T1DM heart (Fig. 2B-2D) [19-21]. 
CG activity was higher in T1DM mice compared to age-matched control (1.7x103 ± 0.23 RFU/
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min/mg protein vs. 0.6x103 ± 0.12 RFU/min/mg protein). Chymase activity was higher in 
T1DM mice compared to control mice (7.6x103 ± 2.29 RFU/min/mg vs. 4.6x103 ± 1.24 RFU/
min/mg protein). Granzyme B activity was higher in T1DM mice compared to control mice 
(3.9x103 ± 0.34 RFU/min/mg protein vs. 2.3x103 ± 0.30 RFU/min/mg protein) (Fig. 2B-2D).
DPPI-KO attenuates STZ induced cardiac inflammation
The observed increase in DPPI expression in T1DM heart suggests that the enzyme 








Fig. 1.  STZ treatment increases leukocyte infiltration, DPPI expression and activation. LV sections from 
animals treated with citrate buffer or STZ for 4-20 weeks were assessed for anti-DPPI immunostaining 
(400X magnification with scale bars 50 µm) (A) and quatification (B), DPPI activity as determined by 
specific fluorogenic substrates (C), and DPPI immunoblot analysis (D). Double immunistaining with DPPI 
and NIMP-R14 (neutrophil), chymase (mast cells), or granzyme B (cytotoxic T cells) antibodies (400X 
magnification with scale bars 50 µm)  (E) and quantification (F), respectively. n=5 for each group *=p< 0.05 
vs control.  One-way ANOVA followed by the Tukey post hoc test was used to compare multiple groups. 
Two-way ANOVA and subsequent Tukey test were performed to compare groups with different time points.
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mice to STZ injection in parallel with WT mice. A lack of DPPI activity was confirmed in DPPI-
KO mice both in the controls and STZ group (Fig. 2A). With IHC, we quantified neutrophil, 
mast cells, and CTL infiltration in STZ treated WT (WT-T1DM) and STZ treated-DPPI-KO 
(DPPI-KO-T1DM) mouse hearts. All three cell types were significantly decreased in DPPI-KO 
compared to WT (1.3 ± 0.33, 0.5 ± 0.34, 1.0 ± 0.37 versus 9.3 ± 0.42, 8.0 ± 0.29, 7.0 ± 0.29, 
respectively) (Fig. 2E & 2F). Examination of the same serine proteases that are activated by 
DPPI and increased in T1DM revealed a significant reduction in their activity in DPPI-KO 
group (Fig. 2B-2D). Previous studies have demonstrated that pro-inflammatory cytokines, 
such as interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α), serve as chemotactic 
factors for leukocytes to diabetic cardiac tissue [31, 32]. T1DM cardiac tissue demonstrated 
a statistically significant increase in the expression of all these cytokines (1.5 ± 0.02 and 
1.3 ± 0.07 fold increase, respectively). DPPI-KO-T1DM mice expressed these molecules at 
essentially the same levels as did the WT-control group (Fig. 2G & 2H).
DPPI deletion has no impact on fasting glucose levels in T1DM mice
Blood glucose levels in T1DM mice were significantly elevated compared to WT-control. 
Interestingly, blood glucose levels were not significantly different between WT-T1DM mice 
and DPPI-KO-T1DM mice (Fig. 3A). Hemoglobin A1c (HbA
1c
) also confirmed the induction of 
diabetes in both WT and DPPI-KO treated with STZ (Fig. 3B).
Fig. 2.  DPPI deletion reduces ISP activity and inflammation after diabetes induction. DPPI (A), cathespin 
G (CG) (B), chymase (C), and granzyme B (D) activity levels in the left ventricular heart as determined by 
enzymatic activity assay (n=5 for each group). (E) Representative NIMP-R14, chymase, and granzyme B 
immunstaining of paraffin-embedded heart sections of WT and DPPI subjected to diabetes induction (400X 
magnification with scale bars 50 µm). (F) Quantification of NIMP-R14, chymase, and granzyme B-positive 
cells (n=5 for each groups). Real-time qPCR analysis of IL-6 (G) and TNF-α (H) in controls and after diabetes 
induction in WT and DPPI-KO mice heart (n=5 for each groups). The data were normalized to GAPDH and 
were expressed as mean ± SEM. *P<0.05 vs. control, #P<0.05 vs. STZ-treated WT. One-way ANOVA followed 
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Cardiac functions in STZ induced T1DM model
We further investigated development of cardiomyopathy in STZ-induced diabetic 
animals by using echocardiography to measure cardiac functions that include LV ejection 
fraction (EF), fractional shortening (FS), LV end diastolic dimension (LVEDD), E/A ratio, 
LV chamber dilation (determined by the LV end diastolic dimension to LV wall thickness 
[LVEDD/PWT]) ratio, and LV end systolic dimension (LVESD). Induction of diabetes led to a 
significant reduction in LV EF, LV FS, and E/A ratio in the WT-T1DM compared to WT-controls 
(Fig. 4A-4C). At 4 weeks post induction of T1DM, average LV EF was 58.5 ± 1.96 in WT-T1DM 
mice compared to 67.2 ± 1.40 in WT-controls. Similarly, average LV FS was 30.9 ± 1.21 in WT-
T1DM  mice compared to 36.7 ± 1.07 in WT-controls. Also the average E/A ratio in WT-T1DM 
mice was 0.9 ± 0.01 compared to 1.1 ± 0.01 in WT-controls (Fig. 4A-4C). The LVEDD, LVEDS, 
and LVEDD/PWT ratio also increased significantly in the WT-T1DM group compared to the 
WT-control group (Fig. 4D-4F).
Development of cardiac hypertrophy in STZ induced T1DM mice
Cardiac hypertrophic markers were also analyzed after diabetes induction by qRT-PCR 
in these groups. Compared to WT-control, atrial natriuretic peptide (ANP) in the WT-T1DM 
demonstrated a significant increase of ~ 7 fold change (P<0.0001) (Fig. 4G); brain natriuretic 
peptide (BNP) showed a 2 fold increase (P<0.0001) (Fig. 4H); and beta-myosin heavy chain 
(β-MHC) demonstrated a ~ 4 fold change increase (P<0.0001) (Fig. 4I).
When myocyte cross-sectional area (CSA) was measured as an index of cardiac 
hypertrophy by means of WGA staining, we found that myocyte CSA was significantly 
increased in WT-T1DM mice compared to WT-control (Fig. 4J & 4K).
DPPI deletion improves cardiac function in T1DM
There were no significant differences between the baseline echocardiographic studies 
and measurements of hypertrophic markers in the WT and DPPI-KO- control mice (Fig. 4). 
Compared to WT-T1DM mice, DPPI-KO-T1DM mice demonstrated significantly increased LV 
EF (64.2 ± 1.06 vs. 58.5 ± 1.96, P<0.0446), LV FS (34.4 ± 0.86 vs. 30.9 ± 1.21, P<0.0351), and 
E/A ratio (1.1 ± 0.01 vs. 0.9 ± 0.00, P<0.0001) (Fig. 4A-4C). LVEDD, LVESD, and LVEDD/PWT 
were all 1.1-1.3 significantly decreased in DPPI-KO-T1DM mice compared to WT-T1DM mice 
(4D-4F).
DPPI-KO-T1DM expressed significantly decreased ANP, BNP, and β-MHC with expression 
levels near baseline levels in WT-control mice (Fig. 4G-4I). Myocyte CSA was also reduced in 
DPPI-KO-T1DM mice compared to WT-T1DM mice, to near baseline levels as in WT-control 
group (Fig. 4J & 4I).
DPPI deletion attenuates cardiac fibrosis in T1DM mice
We then studied collagen content in mice hearts because the deposition influences 
the passive mechanical properties of the myocardium, which then affects the cardiac 
performance [33-36]. Quantitative analysis of total collagen revealed the predicted increase 
in both interstitial and perivascular collagen deposition in WT-T1DM mice compared to WT-
control mice (Fig. 5A). DPPI-KO-T1DM mice showed a significantly reduced degree of collagen 
Fig. 3.  DPPI deletion improves the metabolic 
profile of diabetic mice.  (A) Blood glucose 
levels. (B) Hemoglobulin A1c. Data are 
expressed as means ± SEM (n=10-15; only 5 
animals are shown in each group).*=p< 0.05 vs 
control and #=p<0.05 vs STZ-treated WT. One-
way ANOVA followed by the Tukey post hoc test 
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deposition compared to WT-T1DM mice, with DPPI-KO decreasing collagen deposition levels 
to near baseline levels observed in WT-control mice (Fig. 5A).
To further validate the anti-fibrotic effect of DPPI deletion in STZ-induced T1DM at 
message level, we used qRT-PCR to evaluate the mRNA expression levels of the fibrotic 
genes (collagen, fibronectin), and profibrotic genes CTGF,TGF-β and MMP9. We found 
Fig. 4.  DPPI deletion improve cardiac function and remodeling induced by T1DM after STZ injection 
independently of hyperglycemia. (A-F) Echocardiography measurement of left ventricular (LV) ejection 
fraction (A), fractional shortening (B), E/A ratio (C), LV end diastolic (D) and systolic (E) dimension, and 
LV end diastolic dimension to wall thickness ration (LVEDD/PWT) ratio (F) in control and STZ-induced 
diabetic animals. (G-I) Expression of cardiac remodeling markers, atrial natriuretic peptide (ANP), B-type 
natriuretic peptite (BNP) hypertophic markers, and beta myosin heavy chain (β-MHC).  (J) Representative 
images of WGA staining in the controls and diabetic hearts (400X magnification with scale bars 50 µm). (H-
K) Quantitative analysis of myocyte cross-sectional area. Data are expressed as means ± SEM (n=10-15; only 
5 animals are shown in each group).*=p< 0.05 vs control and #=p<0.05 vs STZ-treated WT. One-way ANOVA 
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that fibronectin, collagen I, and collagen IV were significantly increased in WT-T1DM 
mice compared to WT-control group (Fig. 5B-5D). DPPI deletion significantly decreased 
fibronectin, collagen I, and collagen IV message levels compared to WT-T1DM mice (Fig. 5B-
5D). T1DM cardiac tissue demonstrated marked increases in the expression of TGF-β and 
CTGF (Fig. 5E&5F). DPPI deletion significantly reduced this increase (Fig. 5E & 5F). MMP9 
expression was also significantly decreased in the DPPI-KO-T1DM mice compared to the WT-
T1DM mice (Fig. 5G).
DPPI deletion inhibits cardiomyocyte apoptosis induced by T1DM
We used TUNEL staining to assess the degree of apoptotic cell death in cardiac tissue. 
DPPI-KO-T1DM mice had a significantly reduced number of TUNEL-positive myocytes 
when compared to WT-T1DM mice (Fig. 6A). Cardiac caspase-3 activity was also reduced 
in the DPPI-KO-T1DM group compared to the WT-T1DM group (Fig. 6B). T1DM-WT mice 
had significantly elevated expression of pro-apoptotic proteins Bax (100%, P-0.05) (Fig. 6C 
& 6D) and cleaved caspase-3 (70%, p<0.05) (Fig. 6C & 6F) compared to WT-control. Anti-
apoptotic Bcl-2 levels were decreased in WT-T1DM mice compared to WT-control group (Fig. 
6C & 6E). Cardiac cleaved caspase-3 expression and Bax were all significantly decreased in 
DPPI-KO-T1DM mice compared to WT-T1DM mice (Fig. 6C, 6D, & 6F).
Analysis of the Bax/Bcl-2 ratio, an indicator of activation of the mitochondria-mediated 
apoptotic pathway, showed a significant increase in WT-T1DM mice compared to WT-control 
Fig. 5. DPPI deletion attenuated fibrosis induced by T1DM. (A) Histological sections of left ventricular 
cardiac staining by picrosirius red and semiquantitative analysis was done by a computer imaging system 
(400X magnification with scale bars 50 µm). (B-G) cardiac mRNA expression of fibronectin (B), collagen I (C), 
collagen IV (D), TGF-β (E), connective tissue growth factor (CTGF) (F), and MMP9 (G). Data are presented 
as mean ± SEM. n=5 for each group. *=p< 0.05 vs control and #=p<0.05 vs STZ-treated WT. One-way ANOVA 
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(Fig. 6G). The Bax/Bcl-2 ratio was significantly decreased in DPPI-KO-T1DM group compared 
to the WT-T1DM group.
To better understand how DPPI modulates apoptosis, we conducted a throughput 
analysis of pathways involved in the regulation of apoptosis and inflammation. We measured 
the expression of p38 and AKT to identify the impact of DPPI-KO on upstream apoptotic 
signaling in the myocardium. In T1DM cardiac tissue, the p38 phosphorylation was activated, 
however no significant changes have been found with AKT phosphorylation. With DPPI-KO-
T1DM mice, expression of p38 phosphorylation was significantly normalized back to the 
baseline in WT-control mice (Fig. 7A & 7B).
Fig. 6. Myocardial cell apoptosis assessed by TUNEL staining and cardiac caspase-3 protein expression 
before and after diabetes induction. (A)  Left ventricular (LV) tissue sections were assessed for apoptosis 
with the use of the terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) assay (green), 
tropomyosin (red), and DAPI (4′,6-diamidino-2-phenylindole; blue) staining and the number of TUNEL-
positive myocytes was expressed as a percentage of total nuclei detected by DAPI staining (600X magnification 
with scale bars 40 µm). (B) Quantification of caspase-3 activity in LV with the use of caspase-3–specific 
fluorogenic substrate. RFU indicates relative fluorescence units. Immunoblot analysis and quantification of 
cardiac expression of Bax (C & D), Bcl-2 (C & E) and cleaved caspase-3 (C & F). (G) Bax/Bcl-2 ratio. Data are 
presented as mean ± SEM. n=5 for each group. *=p< 0.05 vs control and #=p<0.05 vs STZ-treated WT. One-











Cell Physiol Biochem 2019;53:982-998
DOI: 10.33594/000000190
Published online: 13 December 2019 993
Cellular Physiology 
and Biochemistry
© 2019 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Kolpakov et al.: Inflammatory Serine Proteases and DCM
DPPI deletion prevents diabetes-induced endoplasmic reticulum (ER) stress as well as the 
associated ER cell death pathway
Increasing evidence suggesting that ER stress and associated apoptotic cell death are 
involved in the development of DCM [37-40]. In the present study, immunoblot analysis 
revealed significant increases in GRP78 (Fig. 7C) but no changes has been found with CHOP 
(Fig. 7D) in diabetic mice; however, these changes were not seen in DPPI-KO-T1DM mice.
Discussion
As the incidence and prevalence of diabetes continued to rise, it is becoming increasingly 
important to understand its cardiovascular complications. This study establishes DPPI as a 
critical component of the early development of impaired cardiac function in mice with T1DM 
and illustrates the impact of global DPPI deletion on cardiac remodeling following T1DM induction.
Fig. 7. Signal transduction mechanisms involved in the induction of apoptosis by inflammatory serine 
protease. (A) Representative Immunoblots of LV lysates from control and diabetic WT or DPPI-KO animals. 
(A) Top, Immunoblots analysis of phosphor-AKTSer473, (B) phopsho-p38hr180/182, (C) GRP78, and (D) CHOP 
expression in the LV heart tissue. Botton, Quantification of the experiments represented as fold change 
compared to WT animals Data are expressed as means ± SEM (n=5).*=p< 0.05 vs control and #=p<0.05 vs 
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The role of DPPI in the development of DCM in T1DM has never been examined 
prior to this study. To shed light on the importance of DPPI to cardiologic impairment, 
we demonstrated that DPPI-KO-T1DM mice experience drastic reductions in nearly all 
inflammatory markers. DPPI deletion causes a reversal of cardiac dysfunction induced by 
T1DM to near baseline levels, most likely by inhibiting p38 phosphorylation, which reduces 
ER stress and apoptosis.
We found that diabetes induction leads to heart dysfunction by triggering a spike in 
DPPI expression which was found to be predominantly expressed in inflammatory cells, 
especially neutrophils, mast cells, and cytotoxicT cells within myocardium. Out of the 
three cell types, neutrophils constituted the largest DPPI-positive population found from 
co-expressions of NIMP-R14 and DPPI together in LV heart. As a positive feedback of the 
inflammatory cascade, all the DPPI activated downstream serine proteases like cathepsin 
G, granzyme B, and chymase were found to have high activity levels in WT-T1DM hearts. As 
a possible consequence several major pro-inflammatory cytokines (such as TNF-α and IL-
6) were significantly increased by WT-T1DM mice compared to control group. The overall 
inflammation found to be an early event during cardiac remodeling orchestrated by DPPI. 
Since the blood glucose levels remained high in T1DM group even after DPPI deletion, it 
supports the previously published data [41, 42] that suggests that DPPI does not affect 
glucose metabolism but it prevents cardiac inflammation to prevent downstream damage 
to prevent DCM.
T1DM led to changes in cardiac structure and function. Echocardiographic findings were 
drastically abnormal (e.g., reduced LV EF and LV FS and decreased E/A ratio) in the diabetic 
mice compared to controls. The overall measurements in the T1DM mice were representative 
of decreased cardiac function and cardiac efficiency. Cardiac hypertrophy has been shown 
to be associated with characteristic alterations in gene expression, including up-regulation 
of ANP and BNP [43, 44], and recapitulation of fetal patterns for expression of myosin heavy 
chains [45-47]. In agreement with the later, message levels of ANP, BNP and β-MHC were 
significantly elevated in the T1DM cardiac tissue compared to its control counterpart. In 
addition, myocyte CSA displayed a significant increase in T1DM-WT mice compared to WT 
control. Both interstitial and perivascular deposition of collagen increased significantly in 
T1DM cardiac tissue compared to WT-control mice. DPPI-KO-T1DM group ameliorated the 
above mentioned structural and functional changes including collagen deposition.
We also found that T1DM increased intracellular stress and damage. When we measured 
protein levels of ER stress markers GRP78.  The CHOP expression level may change at 
the later time point. Also, we performed TUNEL staining in order to assess the degree of 
apoptotic cell death following ER stress and CHOP activation. We found a significantly higher 
number of TUNEL positive cells in WT-T1DM-LV heart compared to WT-control. Subsequently 
pro-apoptotic proteins like Bax and cleaved caspase-3 were significantly increased while 
anti-apoptotic Bcl-2 was significantly reduced in WT-T1DM heart. All of these detrimental 
changes in terms of apoptosis and ER stress reverted to normal levels in DPPI-KO-T1DM 
mice compared to WT-T1DM group.
The induction of myocyte death has been proposed to be a principal factor leading to the 
tissue fibrosis [26]. Our study reinforces this concept through the finding of both decreased 
apoptosis and collagen deposition in DPPI-KO-T1DM mice compared to WT-T1DM mice. 
Some studies have proposed a direct effect of DPPI on fibrosis through TGF-β and stimulation 
of fibroblast differentiation prompting ECM synthesis [48]. In this study, we show that 
DPPI deletion decreases the expression of fibronectin, collagen, TGF-β, CTGF and MMP-9 in 
cardiac tissue, hence prevents fibrosis. Inhibition in TGF-β signaling leads to deactivation 
of p38 signaling through TAK1 mediated pathway [49]. This can inhibit caspase-mediated 
apoptosis [50, 51]. In addition, GRP78 mediated ER stress can activate p38 signaling that can 
execute caspase mediated apoptosis mediated DNA fragmentation and cell death [52-54].
Based on the findings from our study, it appears likely that DPPI deletion in diabetic heart 
inhibits inflammatory and fibrotic development through attenuation of pro-inflammatory 
cytokines and TGF-β signaling. This downregulates TGF-β/TAK1 mediated P38/JNK pathway 
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or GRP78 mediated CHOP activation. Both in turn prevent cell death that leads to cardiac 
fibrosis during development of DCM in diabetic mice. Our study is unique in the sense that it 
first describes how DPPI-KO halts the acute stages of inflammation, which is necessary to the 
development of DCM.  It also suggests that early stage in DCM is very important and can be 
clinically targeted for drug development since DPPI mediated inflammatory cascade remains 
maximally expressed at this point that causes myocyte death and cardiac dysfunction in 
long run.  Our data suggests that modulation of the expression of DPPI or its downstream 
serine proteases could eventually evolve into a therapy given to individuals long before they 
develop the irreversible symptoms of overt heart failure. This has been described in many 
inflammatory models, but this is the first time it has been documented in a T1DM model of 
DCM [55, 56].
Conclusion
In conclusion, DPPI likely plays an important role in the early stages of DCM. T1DM 
is a lifelong, chronic disease, and it is well known that the initial stages of DCM in humans 
are characterized by asymptomatic abnormalities in cardiac function. Our findings indicate 
that DPPI is a potential pharmacological target that may be useful in ameliorating the 
inflammatory cascade responsible for DCM. Further studies focused on identifying the 
specific cells responsible and key mechanisms will be integral to developing specific targets 
for therapy. Together, these studies may be used to engineer preventative medications, 
vaccines, or direct cures for DCM.
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